Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Research Reports

Pharmaceutical Contract Sales Outsourcing Market Statistics, Demand and Forecasts to 2031 Examined in New Research Report

Published On :

Pharmaceutical Contract Sales Outsourcing (CSO) Market: Introduction

According to the report, the global pharmaceutical contract sales outsourcing (CSO) market was valued at US$ 7 Bn in 2020 and is projected to expand at a CAGR of ~7% from 2021 to 2031. Increase in R&D and other operating costs in pharmaceutical industries induces medium and large pharmaceutical companies to outsource their sales operations, as it offers cost controls, better results, and flexibility in terms of operations is anticipated to drive the global pharmaceutical contract sales outsourcing (CSO) market from 2021 to 2031.

Read Report Overview – https://www.transparencymarketresearch.com/pharmaceutical-contract-sales-outsourcing-market.html

North America is expected to account for a significant share of the global pharmaceutical contract sales outsourcing (CSO) market during the forecast period. Well-established healthcare, early adoption of technologically advanced services, and increase in acceptance & demand for pharmaceutical contract sales outsourcing services are the major factors likely to drive the market in the region during the forecast period. The market in Asia Pacific is projected to expand at a high CAGR from 2021 to 2031.

Digitalization of Services Provided by CSOs to Propel Market

Improved and advanced services provided by CSOs such as in the field of non-personal promotions are anticipated to drive the global market during the forecast period. Large as well as small pharmaceutical companies are looking for drugs to cost effectively and quickly enter their pipelines and CSOs play an important role in this endeavor.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28562

The rise in virtual detailing in outsourcing services is increasing dependence on CSO services. The surge in the usage of teledetailng propels the non-personal promotion of outsourcing. These advanced functions, including sales force and customer support are well-established in a CSO, and hence, can help the brand to get market recognition faster.

Personal Promotion to Dominate Global Market

In terms of service, the global pharmaceutical contract sales outsourcing (CSO) market has been classified into personal promotion, non-personal promotion, and others. The personal promotion segment has been split into promotional sales team, key account management, and vacancy management. The non-personal promotion segment has been segregated into tele-detailing, interactive e-detailing, customer service, medical science liaisons, patient engagement services, and others.

Request for Analysis of COVID-19 Impact on Pharmaceutical Contract Sales Outsourcing (CSO) Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=28562

The personal promotion segment is expected to dominate the global pharmaceutical contract sales outsourcing (CSO) market from 2021 to 2031. Significant increase in research & development costs, technological advancements, and product innovations have induced several pharmaceutical companies to outsource sales services to CSOs. This drives the personal promotion services segment.

Oncology to Grow at Faster Rate

Based on therapeutic area, the global pharmaceutical contract sales outsourcing (CSO) market has been categorized into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment is likely to expand at a higher CAGR during the forecast period.

Pre Book Pharmaceutical Contract Sales Outsourcing (CSO) Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=28562&ltype=S

Competition Landscape

The report provides profiles of leading players operating in the global pharmaceutical contract sales outsourcing (CSO) market. These include Ashfield (UDG Healthcare plc), inVentiv Health, Inc. (Syneos Health), IQVIA, Granard Pharmaceutical Sales & Marketing, Vanguard Pharma, Inc., GTS Solution, EVERSANA, MaBiCo, QFR Solutions, Pharmaforce Ireland Ltd., Sales Focus, Inc., Amplity Health, and PharmaLex GmbH.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Mr. Rohit Bhisey

Transparency Market Research

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Blog: https://tmrblog.com/

Follow UsTwitter | LinkedIn

Press Release Source: https://www.transparencymarketresearch.com/pressrelease/pharmaceutical-contract-sales-outsourcing-market.htm

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts